patent for semaglutide expires next year: Novo Nordisk faces tough competition in the Chinese obesity market Your Questions Answered: Off-patent Semaglutide

For a product class where peptide stability, device compatibility, and analytical comparability have historically delayed generic entry, back-to-back authorizations from two of the world's most demanding regulators reflect the depth of the development and quality work behind it

In contrast, no benefits on the rate of decline in glomerular filtration rate have been seen in trials of DPP-4 inhibitors, perhaps because the renal actions of DPP-4 inhibitors are primarily mediated by potentiation of SDF-1, not GLP-1

ROX gets more emphasis than RIV. Source for the written pronunciation is USP Dictionary Online and MedlinePlus.gov Source for the spoken pronunciation = Thank for listening to the 65th episode in my drug pronunciation series

Discover the latest on Ozempic and the new semaglutide Australia brand, Wegovy, approved for chronic weight management available in Australia.

Researchers investigate the weight loss outcomes of semaglutide treatment in obese patients with type 2 diabetes.

While most people associate GLP-1 with weight-loss injections, this system goes far beyond that